Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemiaFary Diop, Gianluca Gaïdano, Clive Jabangwe et al.|Haematologica|2019Cited by 87
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Paola Boggione et al.|Expert Opinion on Therapeutic Targets|2020Cited by 26
Potential of BCL2 as a target for chronic lymphocytic leukemia treatmentRiccardo Moia, Gianluca Gaïdano, Fary Diop et al.|Expert Review of Hematology|2018Cited by 19
An update on: molecular genetics of high-risk chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Andrea Patriarca et al.|Expert Review of Hematology|2019Cited by 10
XPO1 Mutations May Identify Binet Α Chronic Lymphocytic Leukemia Patients with Shorter Time to First TreatmentRiccardo Moia, Gianluca Gaïdano, Chiara Favini et al.|Blood|2019Cited by 3